Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody
Anti-MDA-5 antibody is closely associated with interstitial lung disease (ILD) in amyopathic dermatomyositis (ADM). Patients with ADM with anti-MDA-5 antibody sometimes develop fatal ILD in spite of intensive immunosuppressive therapy. However, an initial decrease after treatment in anti-MDA-5 antib...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Takada, Toshinori [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report - Hung, Shuo-Wen ELSEVIER, 2021, Burlington, Mass |
|---|---|
| Übergeordnetes Werk: |
volume:141 ; year:2018 ; pages:7-13 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.rmed.2018.06.012 |
|---|
| Katalog-ID: |
ELV043875890 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV043875890 | ||
| 003 | DE-627 | ||
| 005 | 20230624105401.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181113s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.rmed.2018.06.012 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000342.pica |
| 035 | |a (DE-627)ELV043875890 | ||
| 035 | |a (ELSEVIER)S0954-6111(18)30203-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.52 |2 bkl | ||
| 100 | 1 | |a Takada, Toshinori |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody |
| 264 | 1 | |c 2018 | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Anti-MDA-5 antibody is closely associated with interstitial lung disease (ILD) in amyopathic dermatomyositis (ADM). Patients with ADM with anti-MDA-5 antibody sometimes develop fatal ILD in spite of intensive immunosuppressive therapy. However, an initial decrease after treatment in anti-MDA-5 antibody titers may not be predictive of subsequent better survival of the disease. | ||
| 650 | 7 | |a Anti-MDA-5 antibody |2 Elsevier | |
| 650 | 7 | |a Dermatomyositis |2 Elsevier | |
| 650 | 7 | |a IL-15 |2 Elsevier | |
| 650 | 7 | |a Interstitial lung disease |2 Elsevier | |
| 650 | 7 | |a IL-10 |2 Elsevier | |
| 700 | 1 | |a Ohashi, Kazumasa |4 oth | |
| 700 | 1 | |a Hayashi, Masachika |4 oth | |
| 700 | 1 | |a Asakawa, Katsuaki |4 oth | |
| 700 | 1 | |a Sakagami, Takuro |4 oth | |
| 700 | 1 | |a Kikuchi, Toshiaki |4 oth | |
| 700 | 1 | |a Sato, Shinji |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Harcourt |a Hung, Shuo-Wen ELSEVIER |t Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |d 2021 |g Burlington, Mass |w (DE-627)ELV009124330 |
| 773 | 1 | 8 | |g volume:141 |g year:2018 |g pages:7-13 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.rmed.2018.06.012 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.52 |j Therapie |x Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 141 |j 2018 |h 7-13 |g 7 | ||
| author_variant |
t t tt |
|---|---|
| matchkey_str |
takadatoshinoriohashikazumasahayashimasa:2018----:oefl5nnesiilugiessnmoahcemtmoi |
| hierarchy_sort_str |
2018 |
| bklnumber |
44.52 |
| publishDate |
2018 |
| allfields |
10.1016/j.rmed.2018.06.012 doi GBV00000000000342.pica (DE-627)ELV043875890 (ELSEVIER)S0954-6111(18)30203-8 DE-627 ger DE-627 rakwb eng 610 VZ 44.52 bkl Takada, Toshinori verfasserin aut Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody 2018 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Anti-MDA-5 antibody is closely associated with interstitial lung disease (ILD) in amyopathic dermatomyositis (ADM). Patients with ADM with anti-MDA-5 antibody sometimes develop fatal ILD in spite of intensive immunosuppressive therapy. However, an initial decrease after treatment in anti-MDA-5 antibody titers may not be predictive of subsequent better survival of the disease. Anti-MDA-5 antibody Elsevier Dermatomyositis Elsevier IL-15 Elsevier Interstitial lung disease Elsevier IL-10 Elsevier Ohashi, Kazumasa oth Hayashi, Masachika oth Asakawa, Katsuaki oth Sakagami, Takuro oth Kikuchi, Toshiaki oth Sato, Shinji oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:141 year:2018 pages:7-13 extent:7 https://doi.org/10.1016/j.rmed.2018.06.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 141 2018 7-13 7 |
| spelling |
10.1016/j.rmed.2018.06.012 doi GBV00000000000342.pica (DE-627)ELV043875890 (ELSEVIER)S0954-6111(18)30203-8 DE-627 ger DE-627 rakwb eng 610 VZ 44.52 bkl Takada, Toshinori verfasserin aut Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody 2018 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Anti-MDA-5 antibody is closely associated with interstitial lung disease (ILD) in amyopathic dermatomyositis (ADM). Patients with ADM with anti-MDA-5 antibody sometimes develop fatal ILD in spite of intensive immunosuppressive therapy. However, an initial decrease after treatment in anti-MDA-5 antibody titers may not be predictive of subsequent better survival of the disease. Anti-MDA-5 antibody Elsevier Dermatomyositis Elsevier IL-15 Elsevier Interstitial lung disease Elsevier IL-10 Elsevier Ohashi, Kazumasa oth Hayashi, Masachika oth Asakawa, Katsuaki oth Sakagami, Takuro oth Kikuchi, Toshiaki oth Sato, Shinji oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:141 year:2018 pages:7-13 extent:7 https://doi.org/10.1016/j.rmed.2018.06.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 141 2018 7-13 7 |
| allfields_unstemmed |
10.1016/j.rmed.2018.06.012 doi GBV00000000000342.pica (DE-627)ELV043875890 (ELSEVIER)S0954-6111(18)30203-8 DE-627 ger DE-627 rakwb eng 610 VZ 44.52 bkl Takada, Toshinori verfasserin aut Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody 2018 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Anti-MDA-5 antibody is closely associated with interstitial lung disease (ILD) in amyopathic dermatomyositis (ADM). Patients with ADM with anti-MDA-5 antibody sometimes develop fatal ILD in spite of intensive immunosuppressive therapy. However, an initial decrease after treatment in anti-MDA-5 antibody titers may not be predictive of subsequent better survival of the disease. Anti-MDA-5 antibody Elsevier Dermatomyositis Elsevier IL-15 Elsevier Interstitial lung disease Elsevier IL-10 Elsevier Ohashi, Kazumasa oth Hayashi, Masachika oth Asakawa, Katsuaki oth Sakagami, Takuro oth Kikuchi, Toshiaki oth Sato, Shinji oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:141 year:2018 pages:7-13 extent:7 https://doi.org/10.1016/j.rmed.2018.06.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 141 2018 7-13 7 |
| allfieldsGer |
10.1016/j.rmed.2018.06.012 doi GBV00000000000342.pica (DE-627)ELV043875890 (ELSEVIER)S0954-6111(18)30203-8 DE-627 ger DE-627 rakwb eng 610 VZ 44.52 bkl Takada, Toshinori verfasserin aut Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody 2018 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Anti-MDA-5 antibody is closely associated with interstitial lung disease (ILD) in amyopathic dermatomyositis (ADM). Patients with ADM with anti-MDA-5 antibody sometimes develop fatal ILD in spite of intensive immunosuppressive therapy. However, an initial decrease after treatment in anti-MDA-5 antibody titers may not be predictive of subsequent better survival of the disease. Anti-MDA-5 antibody Elsevier Dermatomyositis Elsevier IL-15 Elsevier Interstitial lung disease Elsevier IL-10 Elsevier Ohashi, Kazumasa oth Hayashi, Masachika oth Asakawa, Katsuaki oth Sakagami, Takuro oth Kikuchi, Toshiaki oth Sato, Shinji oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:141 year:2018 pages:7-13 extent:7 https://doi.org/10.1016/j.rmed.2018.06.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 141 2018 7-13 7 |
| allfieldsSound |
10.1016/j.rmed.2018.06.012 doi GBV00000000000342.pica (DE-627)ELV043875890 (ELSEVIER)S0954-6111(18)30203-8 DE-627 ger DE-627 rakwb eng 610 VZ 44.52 bkl Takada, Toshinori verfasserin aut Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody 2018 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Anti-MDA-5 antibody is closely associated with interstitial lung disease (ILD) in amyopathic dermatomyositis (ADM). Patients with ADM with anti-MDA-5 antibody sometimes develop fatal ILD in spite of intensive immunosuppressive therapy. However, an initial decrease after treatment in anti-MDA-5 antibody titers may not be predictive of subsequent better survival of the disease. Anti-MDA-5 antibody Elsevier Dermatomyositis Elsevier IL-15 Elsevier Interstitial lung disease Elsevier IL-10 Elsevier Ohashi, Kazumasa oth Hayashi, Masachika oth Asakawa, Katsuaki oth Sakagami, Takuro oth Kikuchi, Toshiaki oth Sato, Shinji oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:141 year:2018 pages:7-13 extent:7 https://doi.org/10.1016/j.rmed.2018.06.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 141 2018 7-13 7 |
| language |
English |
| source |
Enthalten in Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report Burlington, Mass volume:141 year:2018 pages:7-13 extent:7 |
| sourceStr |
Enthalten in Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report Burlington, Mass volume:141 year:2018 pages:7-13 extent:7 |
| format_phy_str_mv |
Article |
| bklname |
Therapie |
| institution |
findex.gbv.de |
| topic_facet |
Anti-MDA-5 antibody Dermatomyositis IL-15 Interstitial lung disease IL-10 |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
| authorswithroles_txt_mv |
Takada, Toshinori @@aut@@ Ohashi, Kazumasa @@oth@@ Hayashi, Masachika @@oth@@ Asakawa, Katsuaki @@oth@@ Sakagami, Takuro @@oth@@ Kikuchi, Toshiaki @@oth@@ Sato, Shinji @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV009124330 |
| dewey-sort |
3610 |
| id |
ELV043875890 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV043875890</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624105401.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">181113s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.rmed.2018.06.012</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000342.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV043875890</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0954-6111(18)30203-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Takada, Toshinori</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Anti-MDA-5 antibody is closely associated with interstitial lung disease (ILD) in amyopathic dermatomyositis (ADM). Patients with ADM with anti-MDA-5 antibody sometimes develop fatal ILD in spite of intensive immunosuppressive therapy. However, an initial decrease after treatment in anti-MDA-5 antibody titers may not be predictive of subsequent better survival of the disease.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anti-MDA-5 antibody</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dermatomyositis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IL-15</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Interstitial lung disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IL-10</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ohashi, Kazumasa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hayashi, Masachika</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Asakawa, Katsuaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sakagami, Takuro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kikuchi, Toshiaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sato, Shinji</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Hung, Shuo-Wen ELSEVIER</subfield><subfield code="t">Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report</subfield><subfield code="d">2021</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV009124330</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:141</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:7-13</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.rmed.2018.06.012</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">141</subfield><subfield code="j">2018</subfield><subfield code="h">7-13</subfield><subfield code="g">7</subfield></datafield></record></collection>
|
| author |
Takada, Toshinori |
| spellingShingle |
Takada, Toshinori ddc 610 bkl 44.52 Elsevier Anti-MDA-5 antibody Elsevier Dermatomyositis Elsevier IL-15 Elsevier Interstitial lung disease Elsevier IL-10 Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody |
| authorStr |
Takada, Toshinori |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV009124330 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.52 bkl Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody Anti-MDA-5 antibody Elsevier Dermatomyositis Elsevier IL-15 Elsevier Interstitial lung disease Elsevier IL-10 Elsevier |
| topic |
ddc 610 bkl 44.52 Elsevier Anti-MDA-5 antibody Elsevier Dermatomyositis Elsevier IL-15 Elsevier Interstitial lung disease Elsevier IL-10 |
| topic_unstemmed |
ddc 610 bkl 44.52 Elsevier Anti-MDA-5 antibody Elsevier Dermatomyositis Elsevier IL-15 Elsevier Interstitial lung disease Elsevier IL-10 |
| topic_browse |
ddc 610 bkl 44.52 Elsevier Anti-MDA-5 antibody Elsevier Dermatomyositis Elsevier IL-15 Elsevier Interstitial lung disease Elsevier IL-10 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
k o ko m h mh k a ka t s ts t k tk s s ss |
| hierarchy_parent_title |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
| hierarchy_parent_id |
ELV009124330 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV009124330 |
| title |
Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody |
| ctrlnum |
(DE-627)ELV043875890 (ELSEVIER)S0954-6111(18)30203-8 |
| title_full |
Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody |
| author_sort |
Takada, Toshinori |
| journal |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
| journalStr |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
7 |
| author_browse |
Takada, Toshinori |
| container_volume |
141 |
| physical |
7 |
| class |
610 VZ 44.52 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Takada, Toshinori |
| doi_str_mv |
10.1016/j.rmed.2018.06.012 |
| dewey-full |
610 |
| title_sort |
role of il-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-mda-5 antibody |
| title_auth |
Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody |
| abstract |
Anti-MDA-5 antibody is closely associated with interstitial lung disease (ILD) in amyopathic dermatomyositis (ADM). Patients with ADM with anti-MDA-5 antibody sometimes develop fatal ILD in spite of intensive immunosuppressive therapy. However, an initial decrease after treatment in anti-MDA-5 antibody titers may not be predictive of subsequent better survival of the disease. |
| abstractGer |
Anti-MDA-5 antibody is closely associated with interstitial lung disease (ILD) in amyopathic dermatomyositis (ADM). Patients with ADM with anti-MDA-5 antibody sometimes develop fatal ILD in spite of intensive immunosuppressive therapy. However, an initial decrease after treatment in anti-MDA-5 antibody titers may not be predictive of subsequent better survival of the disease. |
| abstract_unstemmed |
Anti-MDA-5 antibody is closely associated with interstitial lung disease (ILD) in amyopathic dermatomyositis (ADM). Patients with ADM with anti-MDA-5 antibody sometimes develop fatal ILD in spite of intensive immunosuppressive therapy. However, an initial decrease after treatment in anti-MDA-5 antibody titers may not be predictive of subsequent better survival of the disease. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody |
| url |
https://doi.org/10.1016/j.rmed.2018.06.012 |
| remote_bool |
true |
| author2 |
Ohashi, Kazumasa Hayashi, Masachika Asakawa, Katsuaki Sakagami, Takuro Kikuchi, Toshiaki Sato, Shinji |
| author2Str |
Ohashi, Kazumasa Hayashi, Masachika Asakawa, Katsuaki Sakagami, Takuro Kikuchi, Toshiaki Sato, Shinji |
| ppnlink |
ELV009124330 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| doi_str |
10.1016/j.rmed.2018.06.012 |
| up_date |
2024-07-06T19:59:16.811Z |
| _version_ |
1803861053209051136 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV043875890</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624105401.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">181113s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.rmed.2018.06.012</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000342.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV043875890</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0954-6111(18)30203-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Takada, Toshinori</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Anti-MDA-5 antibody is closely associated with interstitial lung disease (ILD) in amyopathic dermatomyositis (ADM). Patients with ADM with anti-MDA-5 antibody sometimes develop fatal ILD in spite of intensive immunosuppressive therapy. However, an initial decrease after treatment in anti-MDA-5 antibody titers may not be predictive of subsequent better survival of the disease.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anti-MDA-5 antibody</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dermatomyositis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IL-15</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Interstitial lung disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IL-10</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ohashi, Kazumasa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hayashi, Masachika</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Asakawa, Katsuaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sakagami, Takuro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kikuchi, Toshiaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sato, Shinji</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Hung, Shuo-Wen ELSEVIER</subfield><subfield code="t">Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report</subfield><subfield code="d">2021</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV009124330</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:141</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:7-13</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.rmed.2018.06.012</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">141</subfield><subfield code="j">2018</subfield><subfield code="h">7-13</subfield><subfield code="g">7</subfield></datafield></record></collection>
|
| score |
7.3996515 |